FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Wolf-Hagen Schunck

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Concepts & Ideas

Co-author Network

Publications

TOP 3
Angelika Kusch; L Marko; Dominik N Müller; Kai M Schmidt-Ott; R Schmidt-Ullrich; Wolf-Hagen Schunck; Y Zhu; M Blum; G Bubalo; M Fechner; D Gürgen; Uwe Hoff; Duska Dragun
Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury.
Bahar Tunctan; Demet Unsal; C Kemal Buharalioglu; Tuba Cuez; John R Falck; Meltem Kacan; Belma Korkmaz; Seyhan Sahan-Firat; Ayse Nihal Sari; Wolf-Hagen Schunck; Mehmet Sami Serin; Kafait U Malik
5,14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: Contribution of soluble epoxide hydrolase, CYP2C23, MEK1/ERK1/2/IKKβ/IκB-α/NF-κB pathway, and proinflammatory cytokine formation.
Andreas Pohlmann; Wolf-Hagen Schunck; Erdmann Seeliger; Helmar Waiczies; Sonia Waiczies; Karen Arakelyan; Gordana Bubalo; Kathleen Cantow; Duska Dragun; Mandy Fechner; Bert Flemming; Jan Hentschel; Uwe Hoff; Thoralf Niendorf
High temporal resolution parametric MRI monitoring of the initial ischemia/reperfusion phase in experimental acute kidney injury.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Wolf-Hagen Schunck (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Angelika Kusch; L Marko; Dominik N Müller; Kai M Schmidt-Ott; R Schmidt-Ullrich; Wolf-Hagen Schunck; Y Zhu; M Blum; G Bubalo; M Fechner; D Gürgen; Uwe Hoff; Duska Dragun
Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury.
Acta physiologica (Oxford, England) 2013;208(1):25-40.
2013: Bahar Tunctan; Demet Unsal; C Kemal Buharalioglu; Tuba Cuez; John R Falck; Meltem Kacan; Belma Korkmaz; Seyhan Sahan-Firat; Ayse Nihal Sari; Wolf-Hagen Schunck; Mehmet Sami Serin; Kafait U Malik
5,14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: Contribution of soluble epoxide hydrolase, CYP2C23, MEK1/ERK1/2/IKKβ/IκB-α/NF-κB pathway, and proinflammatory cytokine formation.
Prostaglandins & other lipid mediators 2013;102-103():31-41.
2013: Andreas Pohlmann; Wolf-Hagen Schunck; Erdmann Seeliger; Helmar Waiczies; Sonia Waiczies; Karen Arakelyan; Gordana Bubalo; Kathleen Cantow; Duska Dragun; Mandy Fechner; Bert Flemming; Jan Hentschel; Uwe Hoff; Thoralf Niendorf
High temporal resolution parametric MRI monitoring of the initial ischemia/reperfusion phase in experimental acute kidney injury.
PloS one 2013;8(2):e57411.
2012: Florian Herse; Joachim Hoyer; Carl A Hubel; Berthold Huppertz; Tea Kaartokallio; Michael Kacik; Hannele Laivuori; Babbette Lamarca; A Inkeri Lokki; Friedrich C Luft; Dominik N Muller; Sarah Novotny; Joon-Keun Park; Michael Rothe; Michael J Ryan; Wolf-Hagen Schunck; Anne Cathrine Staff; Meryam Sugulle; Stefan Verlohren; Gerd Wallukat; Justin Brewer; Eeva Ekholm; Martin Gauster; Ralf Dechend
Cytochrome P450 subfamily 2J polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia.
Circulation 2012;126(25):2990-9.
2012: Bahar Tunctan; Demet Unsal; C Kemal Buharalioglu; John R Falck; Meltem Kacan; Belma Korkmaz; Seyhan Sahan-Firat; Ayse Nihal Sari; Wolf-Hagen Schunck; Mehmet Sami Serin; Kafait U Malik
A novel treatment strategy for sepsis and septic shock based on the interactions between prostanoids, nitric oxide, and 20-hydroxyeicosatetraenoic acid.
Anti-inflammatory & anti-allergy agents in medicinal chemistry 2012;11(2):121-50.
2011: Christina Westphal; Anne Konkel; Wolf-Hagen Schunck
CYP-eicosanoids--a new link between omega-3 fatty acids and cardiac disease?
Prostaglandins & other lipid mediators 2011;96(1-4):99-108.
2011: John R Falck; Robert Fischer; Mohan Goli; Anne Konkel; Dominik N Müller; Narender Puli; Michael Rothe; Cosima Arnold; Gerd Wallukat; Wolf-Hagen Schunck
17(R),18(S)-epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: structure-activity relationships and stable analogues.
Journal of medicinal chemistry 2011;54(12):4109-18.
2011: Mandy Kosel; Waltraud Wild; Alexandra Bell; Michael Rothe; Carsten Lindschau; Christian E W Steinberg; Wolf-Hagen Schunck; Ralph Menzel
Eicosanoid formation by a cytochrome P450 isoform expressed in the pharynx of Caenorhabditis elegans.
The Biochemical journal 2011;435(3):689-700.
2011: Beate Gomolka; Elise Siegert; Katrin Blossey; Wolf-Hagen Schunck; Michael Rothe; Karsten H Weylandt
Analysis of omega-3 and omega-6 fatty acid-derived lipid metabolite formation in human and mouse blood samples.
Prostaglandins & other lipid mediators 2011;94(3-4):81-7.
2011: Uwe Hoff; Ivo Lukitsch; Lyubov Chaykovska; Mechthild Ladwig; Cosima Arnold; Vijay L Manthati; T Florian Fuller; Wolfgang Schneider; Maik Gollasch; Dominik N Muller; Bert Flemming; Erdmann Seeliger; Friedrich C Luft; John R Falck; Duska Dragun; Wolf-Hagen Schunck
Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury.
Kidney international 2011;79(1):57-65.
2011: Dieter Schwarz; Pyotr Kisselev; Wolf-Hagen Schunck; Ivar Roots
Inhibition of 17β-estradiol activation by CYP1A1: genotype- and regioselective inhibition by St. John's Wort and several natural polyphenols.
Biochimica et biophysica acta 2011;1814(1):168-74.
2011: Anne Konkel; Wolf-Hagen Schunck
Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids.
Biochimica et biophysica acta 2011;1814(1):210-22.
2010: Cosima Arnold; Marija Markovic; Katrin Blossey; Gerd Wallukat; Robert Fischer; Ralf Dechend; Anne Konkel; Clemens von Schacky; Friedrich C Luft; Dominik N Muller; Michael Rothe; Wolf-Hagen Schunck
Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acids.
The Journal of biological chemistry 2010;285(43):32720-33.
2010: Cosima Arnold; Anne Konkel; Robert Fischer; Wolf-Hagen Schunck
Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids.
Pharmacological reports : PR 2010;62(3):536-47.
2010: Franziska Rompe; Metin Artuc; Anders Hallberg; Mathias Alterman; Katja Ströder; Christa Thöne-Reineke; Anne Reichenbach; Jens Schacherl; Björn Dahlöf; Michael Bader; Natalia Alenina; Markus Schwaninger; Torsten Zuberbier; Heiko Funke-Kaiser; Cosima Schmidt; Wolf-Hagen Schunck; Thomas Unger; U Muscha Steckelings
Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB.
Hypertension 2010;55(4):924-31.
2009: Valéria Lamounier-Zepter; Christiane Look; Julio Alvarez; Torsten Christ; Ursula Ravens; Wolf-Hagen Schunck; Monika Ehrhart-Bornstein; Stefan R Bornstein; Ingo Morano
Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease.
Circulation research 2009;105(4):326-34.
2009: Anja Haase-Fielitz; Michael Haase; Rinaldo Bellomo; Gavin Lambert; George Matalanis; David Story; Laurie Doolan; Brian Buxton; Geoff Gutteridge; Friedrich C Luft; Wolf-Hagen Schunck; Duska Dragun
Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery.
Journal of the American Society of Nephrology : JASN 2009;20(6):1393-403.
2008: Jan Monti; Judith Fischer; Svetlana Paskas; Matthias Heinig; Herbert Schulz; Claudia Gösele; Arnd Heuser; Robert Fischer; Cosima Schmidt; Alexander Schirdewan; Volkmar Gross; Oliver Hummel; Henrike Maatz; Giannino Patone; Kathrin Saar; Martin Vingron; Steven M Weldon; Klaus Lindpaintner; Bruce D Hammock; Klaus Rohde; Rainer Dietz; Stuart A Cook; Wolf-Hagen Schunck; Friedrich C Luft; Norbert Hubner
Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease.
Nature genetics 2008;40(5):529-37.
2008: Jana Kulas; Cosima Schmidt; Michael Rothe; Wolf-Hagen Schunck; Ralph Menzel
Cytochrome P450-dependent metabolism of eicosapentaenoic acid in the nematode Caenorhabditis elegans.
Archives of biochemistry and biophysics 2008;472(1):65-75.
2008: Robert Fischer; Ralf Dechend; Fatimunnisa Qadri; Marija Markovic; Sandra Feldt; Florian Herse; Joon-Keun Park; Andrej Gapelyuk; Ines Schwarz; Udo Zacharzowsky; Ralph Plehm; Erdal Safak; Arnd Heuser; Alexander Schirdewan; Friedrich C Luft; Wolf-Hagen Schunck; Dominik N Muller
Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension.
Hypertension 2008;51(2):540-6.
2007: Hantz Hercule; Birgit Salanova; Kirill Essin; Horst Honeck; John R Falck; Matthias Sausbier; Peter Ruth; Wolf-Hagen Schunck; Friedrich C Luft; Maik Gollasch
The vasodilator 17,18-epoxyeicosatetraenoic acid targets the pore-forming BK alpha channel subunit in rodents.
Experimental physiology 2007;92(6):1067-76.
2007: Katrin Birkenmeier; Alexander Staudt; Wolf-Hagen Schunck; Irka Janke; Corina Labitzke; Thomas Prange; Christiane Trimpert; Thomas Krieg; Martin Landsberger; Verena Stangl; Stephan B Felix
COX-2-dependent and potentially cardioprotective effects of negative inotropic substances released after ischemia.
American journal of physiology. Heart and circulatory physiology 2007;293(4):H2148-54.
2007: Dominik N Muller; Cosima Schmidt; Eduardo Barbosa-Sicard; Maren Wellner; Volkmar Gross; Hantz Hercule; Marija Markovic; Horst Honeck; Friedrich C Luft; Wolf-Hagen Schunck
Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation.
The Biochemical journal 2007;403(1):109-18.
2005: Kathrin Klein; Thomas Lang; Tanja Saussele; Eduardo Barbosa-Sicard; Wolf-Hagen Schunck; Michel Eichelbaum; Matthias Schwab; Uli Zanger
Genetic variability of CYP2B6 in populations of African and Asian origin: allele frequencies, novel functional variants, and possible implications for anti-HIV therapy with efavirenz.
Pharmacogenetics and genomics 2005;15(12):861-73.
2005: Dieter Schwarz; Pyotr Kisselev; Alexey Chernogolov; Wolf-Hagen Schunck; Ivar Roots
Human CYP1A1 variants lead to differential eicosapentaenoic acid metabolite patterns.
Biochemical and biophysical research communications 2005;336(3):779-83.
2005: Eduardo Barbosa-Sicard; Marija Markovic; Horst Honeck; Baghat Christ; Dominik N Muller; Wolf-Hagen Schunck
Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily.
Biochemical and biophysical research communications 2005;329(4):1275-81.
2005: Pyotr Kisselev; Wolf-Hagen Schunck; Ivar Roots; Dieter Schwarz
Association of CYP1A1 polymorphisms with differential metabolic activation of 17beta-estradiol and estrone.
Cancer research 2005;65(7):2972-8.
2005: Juergen Theuer; Erdenechimeg Shagdarsuren; Dominik N Muller; Eva Kaergel; Horst Honeck; Joon-Keun Park; Anette Fiebeler; Ralf Dechend; Hermann Haller; Friedrich C Luft; Wolf-Hagen Schunck
Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage.
Kidney international 2005;67(1):248-58.
2004: Dieter Schwarz; Pyotr Kisselev; Spencer S Ericksen; Grazyna D Szklarz; Alexey Chernogolov; Horst Honeck; Wolf-Hagen Schunck; Ivar Roots
Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid.
Biochemical pharmacology 2004;67(8):1445-57.
2004: Dominik N Muller; Juergen Theuer; Erdenechimeg Shagdarsuren; Eva Kaergel; Horst Honeck; Joon-Keun Park; Marija Markovic; Eduardo Barbosa-Sicard; Ralf Dechend; Maren Wellner; Torsten Kirsch; Anette Fiebeler; Michael Rothe; Hermann Haller; Friedrich C Luft; Wolf-Hagen Schunck
A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury.
The American journal of pathology 2004;164(2):521-32.
2003: Alexey Chernogolov; Joachim Behlke; Wolf-Hagen Schunck; Ivar Roots; Dieter Schwarz
Human CYP1A1 allelic variants: baculovirus expression and purification, hydrodynamic, spectral, and catalytical properties and their potency in the formation of all-trans-retinoic acid.
Protein expression and purification 2003;28(2):259-69.
2002: Eva Kaergel; Dominik N Muller; Horst Honeck; Juergen Theuer; Erdenechimeg Shagdarsuren; Alexander Mullally; Friedrich C Luft; Wolf-Hagen Schunck
P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage.
Hypertension 2002;40(3):273-9.
2002: Vladimir M Shkumatov; EV Usova; Y S Poljakov; N s Frolova; V G Radyuk; Stephan Mauersberger; Alexey Chernogolov; Horst Honeck; Wolf-Hagen Schunck
Biotransformation of steroids by a recombinant yeast strain expressing bovine cytochrome P-45017alpha.
Biochemistry. Biokhimii͡a 2002;67(4):456-67.
2002: Pyotr Kisselev; Dieter Schwarz; Karl-Ludwig Platt; Wolf-Hagen Schunck; Ivar Roots
Epoxidation of benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 in reconstituted membranes. Effects of charge and nonbilayer phase propensity of the membrane.
European journal of biochemistry / FEBS 2002;269(7):1799-805.
2002: Birgit Lauterbach; Eduardo Barbosa-Sicard; Mong-Heng Wang; Horst Honeck; Eva Kärgel; Juergen Theuer; Michal L Schwartzman; Hermann Haller; Friedrich C Luft; Maik Gollasch; Wolf-Hagen Schunck
Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators.
Hypertension 2002;39(2 Pt 2):609-13.
2001: Dieter Schwarz; Pyotr Kisselev; Horst Honeck; Ingolf Cascorbi; Wolf-Hagen Schunck; Ivar Roots
Co-expression of human cytochrome P4501A1 (CYP1A1) variants and human NADPH-cytochrome P450 reductase in the baculovirus/insect cell system.
Xenobiotica; the fate of foreign compounds in biological systems 2001;31(6):345-56.
2001: Dieter Schwarz; Pyotr Kisselev; Ingolf Cascorbi; Wolf-Hagen Schunck; Ivar Roots
Differential metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1 variants.
Carcinogenesis 2001;22(3):453-9.
2000: Horst Honeck; Volkmar Gross; B Erdmann; Eva Kärgel; R Neunaber; A F Milia; W Schneider; Friedrich C Luft; Wolf-Hagen Schunck
Cytochrome P450-dependent renal arachidonic acid metabolism in desoxycorticosterone acetate-salt hypertensive mice.
Hypertension 2000;36(4):610-6.
2000: Dieter Schwarz; Pyotr Kisselev; Wolf-Hagen Schunck; Alexey Chernogolov; W Boidol; Ingolf Cascorbi; Ivar Roots
Allelic variants of human cytochrome P450 1A1 (CYP1A1): effect of T461N and I462V substitutions on steroid hydroxylase specificity.
Pharmacogenetics 2000;10(6):519-30.
2000: Volkmar Gross; Wolf-Hagen Schunck; Horst Honeck; A F Milia; Eva Kärgel; Thomas Walther; M Bader; T Inagami; W Schneider; Friedrich C Luft
Inhibition of pressure natriuresis in mice lacking the AT2 receptor.
Kidney international 2000;57(1):191-202.
1999: G Sandig; Eva Kärgel; R Menzel; F Vogel; Thomas Zimmer; Wolf-Hagen Schunck
Regulation of endoplasmic reticulum biogenesis in response to cytochrome P450 overproduction.
Drug metabolism reviews 1999;31(2):393-410.
1998: U Scheller; Thomas Zimmer; Dörte Becher; Frieder Schauer; Wolf-Hagen Schunck
Oxygenation cascade in conversion of n-alkanes to alpha,omega-dioic acids catalyzed by cytochrome P450 52A3.
The Journal of biological chemistry 1998;273(49):32528-34.
1998: Thomas Zimmer; Toshiya Iida; Wolf-Hagen Schunck; Y Yoshida; Akinori Ohta; Masamichi Takagi
Relation between evolutionary distance and enzymatic properties among the members of the CYP52A subfamily of Candida maltosa.
Biochemical and biophysical research communications 1998;251(1):244-7.
1998: Thomas Zimmer; U Scheller; M Takagi; Wolf-Hagen Schunck
Mutual conversion of fatty-acid substrate specificity by a single amino-acid exchange at position 527 in P-450Cm2 and P-450Alk3A.
European journal of biochemistry / FEBS 1998;256(2):398-403.
1998: U M Stündl; I Schmidt; U Scheller; R Schmid; Wolf-Hagen Schunck; Frieder Schauer
Purification and characterization of cytosolic cytochrome P450 forms from yeasts belonging to the genus Trichosporon.
Archives of biochemistry and biophysics 1998;357(1):131-6.
1998: M Ohkuma; Thomas Zimmer; Toshiya Iida; Wolf-Hagen Schunck; Akinori Ohta; Masamichi Takagi
Isozyme function of n-alkane-inducible cytochromes P450 in Candida maltosa revealed by sequential gene disruption.
The Journal of biological chemistry 1998;273(7):3948-53.
1997: R Menzel; F Vogel; Eva Kärgel; Wolf-Hagen Schunck
Inducible membranes in yeast: relation to the unfolded-protein-response pathway.
Yeast (Chichester, England) 1997;13(13):1211-29.
1997: Thomas Zimmer; F Vogel; A Ohta; M Takagi; Wolf-Hagen Schunck
Protein quality--a determinant of the intracellular fate of membrane-bound cytochromes P450 in yeast.
DNA and cell biology 1997;16(4):501-14.
1996: Thomas Zimmer; M Ohkuma; Akinori Ohta; Masamichi Takagi; Wolf-Hagen Schunck
The CYP52 multigene family of Candida maltosa encodes functionally diverse n-alkane-inducible cytochromes P450.
Biochemical and biophysical research communications 1996;224(3):784-9.
1996: R Menzel; Eva Kärgel; F Vogel; C Böttcher; Wolf-Hagen Schunck
Topogenesis of a microsomal cytochrome P450 and induction of endoplasmic reticulum membrane proliferation in Saccharomyces cerevisiae.
Archives of biochemistry and biophysics 1996;330(1):97-109.
1996: U Scheller; Thomas Zimmer; Eva Kärgel; Wolf-Hagen Schunck
Characterization of the n-alkane and fatty acid hydroxylating cytochrome P450 forms 52A3 and 52A4.
Archives of biochemistry and biophysics 1996;328(2):245-54.
1996: Eva Kärgel; R Menzel; H Honeck; F Vogel; A Böhmer; Wolf-Hagen Schunck
Candida maltosa NADPH-cytochrome P450 reductase: cloning of a full-length cDNA, heterologous expression in Saccharomyces cerevisiae and function of the N-terminal region for membrane anchoring and proliferation of the endoplasmic reticulum.
Yeast (Chichester, England) 1996;12(4):333-48.
1996: U Scheller; T Juretzek; Wolf-Hagen Schunck
Generation of the cytosolic domain of microsomal P450 52A3 after high-level expression in Saccharomyces cerevisiae.
Methods in enzymology 1996;272():65-75.
1995: Thomas Zimmer; K Kaminski; U Scheller; F Vogel; Wolf-Hagen Schunck
In vivo reconstitution of highly active Candida maltosa cytochrome P450 monooxygenase systems in inducible membranes of Saccharomyces cerevisiae.
DNA and cell biology 1995;14(7):619-28.
1995: M Ohkuma; S M Park; Thomas Zimmer; R Menzel; F Vogel; Wolf-Hagen Schunck; Akinori Ohta; Masamichi Takagi
Proliferation of intracellular membrane structures upon homologous overproduction of cytochrome P-450 in Candida maltosa.
Biochimica et biophysica acta 1995;1236(1):163-9.
1995: Thomas Zimmer; Wolf-Hagen Schunck
A deviation from the universal genetic code in Candida maltosa and consequences for heterologous expression of cytochromes P450 52A4 and 52A5 in Saccharomyces cerevisiae.
Yeast (Chichester, England) 1995;11(1):33-41.
1994: K Eichler; Wolf-Hagen Schunck; Hans-Peter Kleber; Marie-Andrée Mandrand-Berthelot
Cloning, nucleotide sequence, and expression of the Escherichia coli gene encoding carnitine dehydratase.
Journal of bacteriology 1994;176(10):2970-5.
1994: U Scheller; R Kraft; K L Schröder; Wolf-Hagen Schunck
Generation of the soluble and functional cytosolic domain of microsomal cytochrome P450 52A3.
The Journal of biological chemistry 1994;269(17):12779-83.
1993: B Wiedmann; P Silver; Wolf-Hagen Schunck; Martin Wiedmann
Overexpression of the ER-membrane protein P-450 CYP52A3 mimics sec mutant characteristics in Saccharomyces cerevisiae.
Biochimica et biophysica acta 1993;1153(2):267-76.
1992: F Vogel; C Gengnagel; Eva Kärgel; H G Müller; Wolf-Hagen Schunck
Immunocytochemical localization of alkane-inducible cytochrome P-450 and its NADPH-dependent reductase in the yeast Candida maltosa.
European journal of cell biology 1992;57(2):285-91.
1991: Wolf-Hagen Schunck; F Vogel; B Gross; Eva Kärgel; S Mauersberger; K Köpke; C Gengnagel; H G Müller
Comparison of two cytochromes P-450 from Candida maltosa: primary structures, substrate specificities and effects of their expression in Saccharomyces cerevisiae on the proliferation of the endoplasmic reticulum.
European journal of cell biology 1991;55(2):336-45.
1991: M Ohkuma; T Hikiji; T Tanimoto; Wolf-Hagen Schunck; H G Müller; Kazuyoshi Yano; Masamichi Takagi
Evidence that more than one gene encodes n-alkane-inducible cytochrome P-450s in Candida maltosa, found by two-step gene disruption.
Agricultural and biological chemistry 1991;55(7):1757-64.
1991: F Vogel; Eva Kärgel; Wolf-Hagen Schunck
In situ localization of cytochrome P-450, the first enzyme involved in aliphatic hydrocarbon degradation in the yeast Candida maltosa.
Progress in histochemistry and cytochemistry 1991;23(1-4):383-9.
1989: Wolf-Hagen Schunck; Eva Kärgel; B Gross; B Wiedmann; S Mauersberger; K Köpke; U Kiessling; M Strauss; Matthias Gaestel; H G Müller
Molecular cloning and characterization of the primary structure of the alkane hydroxylating cytochrome P-450 from the yeast Candida maltosa.
Biochemical and biophysical research communications 1989;161(2):843-50.
1988: B Wiedmann; M Wiedmann; S Mauersberger; Wolf-Hagen Schunck; H G Müller
Oxygen limitation induces indirectly the synthesis of cytochrome P-450 mRNA in alkane-growing Candida maltosa.
Biochemical and biophysical research communications 1988;150(2):859-65.
1986: B Wiedmann; M Wiedmann; Eva Kärgel; Wolf-Hagen Schunck; H G Müller
N-alkanes induce the synthesis of cytochrome P-450 mRNA in Candida maltosa.
Biochemical and biophysical research communications 1986;136(3):1148-54.
1985: Eva Kärgel; Wolf-Hagen Schunck; P Riege; E Honeck; R Clauss; Hans-Peter Kleber; H G Müller
A comparative immunological investigation of the alkane hydroxylating cytochrome P-450 from the yeast Candida maltosa.
Biochemical and biophysical research communications 1985;128(3):1261-7.
1985: H Honeck; Wolf-Hagen Schunck; H G Müller
The function of cytochrome P-450 in fungi and prospects of application.
Die Pharmazie 1985;40(4):221-7.
1982: H Honeck; Wolf-Hagen Schunck; P Riege; H G Müller
The cytochrome P-450 alkane monooxygenase system of the yeast Lodderomyces elongisporus: purification and some properties of the NADPH-cytochrome P-450 reductase.
Biochemical and biophysical research communications 1982;106(4):1318-24.
1981: P Riege; Wolf-Hagen Schunck; H Honeck; H G Müller
Cytochrome P-450 from Lodderomyces elongisporus: its purification and some properties of the highly purified protein.
Biochemical and biophysical research communications 1981;98(2):527-34.
1981: S Mauersberger; Wolf-Hagen Schunck; H H Müller
The induction of cytochrome P-450 in Lodderomyces elongisporus.
Zeitschrift für allgemeine Mikrobiologie 1981;21(4):313-21.